Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition

Abstract Purpose Multigene panels allow simultaneous testing of genes involved in cancer predisposition. Thyroid cancer (TCa) is a component tumor of several cancer predisposition syndromes, but the complete landscape of germline variants predisposing to TCa remains to be determined. Methods Clinica...

Full description

Bibliographic Details
Main Authors:	Junne Kamihara, Jing Zhou, Holly LaDuca, Ari J. Wassner, Emily Dalton, Judy E. Garber, Mary Helen Black
Format:	Article
Language:	English
Published:	Wiley 2022-04-01
Series:	Cancer Medicine
Subjects:	cancer predisposition CHEK2 germline multigene panels thyroid cancer
Online Access:	https://doi.org/10.1002/cam4.4549

Similar Items

Landscape of germline cancer predisposition mutations testing and management in pediatrics: Implications for research and clinical care
by: Shilpa A. Shahani, et al.
Published: (2022-09-01)

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis
by: Arianna Dal Buono, et al.
Published: (2023-03-01)

Genetic Predisposition to Solid Pediatric Cancers
by: Mario Capasso, et al.
Published: (2020-10-01)

Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
by: Juehua Gao, et al.
Published: (2021-12-01)

The First Case Report of a Patient With Oligodendroglioma Harboring CHEK2 Germline Mutation
by: Xueen Li, et al.
Published: (2022-02-01)

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
by: Alberto Puccini, et al.
Published: (2022-09-01)

Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care
by: Pablo Gargallo, et al.
Published: (2021-10-01)

Germline predisposition to glial neoplasms in children and young adults: A narrative review
by: Anirban Das, et al.
Published: (2021-01-01)

Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing
by: Donavan T. Cheng, et al.
Published: (2017-05-01)

Case report: A germline CHEK1 c.613 + 2T>C leads to a splicing error in a family with multiple cancer patients
by: Jun Qian, et al.
Published: (2024-04-01)

Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients
by: Greet Wieme, et al.
Published: (2021-09-01)

Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer
by: Cristina Herrera-Pariente, et al.
Published: (2021-01-01)

<i>CHEK2</i> Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
by: Lenka Stolarova, et al.
Published: (2020-12-01)

The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
by: Andreia Brandão, et al.
Published: (2020-11-01)

Germline <i>POT1</i> Variants: A Critical Perspective on <i>POT1</i> Tumor Predisposition Syndrome
by: Virginia Andreotti, et al.
Published: (2024-01-01)

Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes
by: Lenka Stolarova, et al.
Published: (2020-10-01)

Molecular reclassification reveals low prevalence of germline predisposition in children with ependymoma
by: Jon Foss-Skiftesvik, et al.
Published: (2023-06-01)

Unique ER PR expression pattern in breast cancers with CHEK2 mutation: a hormone receptor and HER2 analysis based on germline cancer predisposition genes
by: Grace Wei, et al.
Published: (2022-02-01)

Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer
by: Louisa Lepkes, et al.
Published: (2021-01-01)

Germline Variants Associated with Nasopharyngeal Carcinoma Predisposition Identified through Whole-Exome Sequencing
by: Ning-Yuan Lee, et al.
Published: (2022-07-01)

Germline <i>ERBB2</i>/<i>HER2</i> Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms
by: Evan M. Braunstein, et al.
Published: (2021-06-01)

Common genetic variation in the germline influences where and how tumors develop
by: Hannah Carter, et al.
Published: (2017-05-01)

Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients
by: Daniele Paixão, et al.
Published: (2022-08-01)

Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?
by: Klara Horackova, et al.
Published: (2023-11-01)

Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
by: Cristina Andrés‐Zayas, et al.
Published: (2021-09-01)

Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies—A Review
by: Aleksandra Filipiuk, et al.
Published: (2022-07-01)

Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis
by: Airat Bilyalov, et al.
Published: (2023-12-01)

TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing
by: Fabienne Lesueur, et al.
Published: (2021-07-01)

Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships
by: Austin A. Saugstad, et al.
Published: (2022-05-01)

Case report: Germline RECQL mutation potentially involved in hereditary predisposition to acute leukemia
by: Wei Yuan, et al.
Published: (2023-03-01)

Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias
by: Raphaelle D. Vallera, et al.
Published: (2022-11-01)

Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients
by: Ayman Al Saati, et al.
Published: (2023-09-01)

A Rare Variant in <i>MDH2</i> (rs111879470) Is Associated with Predisposition to Recurrent Breast Cancer in an Extended High-Risk Pedigree
by: Lisa A. Cannon-Albright, et al.
Published: (2023-12-01)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
by: Airat Bilyalov, et al.
Published: (2022-10-01)

Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late‐onset cancers
by: Shaoyu Hao, et al.
Published: (2023-09-01)

A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data
by: Giorgio E. M. Melloni, et al.
Published: (2017-05-01)

Cancer predisposition syndromes in children
by: D. Yu. Kachanov, et al.
Published: (2022-11-01)

Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants
by: Roni Rasnic, et al.
Published: (2019-08-01)

Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test?
by: Francesca Rebuzzi, et al.
Published: (2023-01-01)

Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer
by: Aayushi Srivastava, et al.
Published: (2021-02-01)